Aeolus Pharmaceuticals, Inc. Stock OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Financials (USD)
Sales 2015 | 3.11M | Sales 2016 | 2.08M | Capitalization | 28.9M |
---|---|---|---|---|---|
Net income 2015 | -2M | Net income 2016 | -3M | EV / Sales 2015 | 10.8 x |
Net Debt 2015 | 908K | Net cash position 2016 | 3.16M | EV / Sales 2016 | 12.4 x |
P/E ratio 2015 |
-12
x | P/E ratio 2016 |
-4.67
x | Employees | - |
Yield 2015 * |
-
| Yield 2016 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
John McManus
CEO | Chief Executive Officer | 60 | 05-05-31 |
David Cavalier
CHM | Chairman | 54 | 04-04-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Cavalier
CHM | Chairman | 54 | 04-04-29 |
Jeffrey Scott
BRD | Director/Board Member | 67 | 13-05-07 |
John Clerici
BRD | Director/Board Member | 54 | 13-05-07 |
1st Jan change | Capi. | |
---|---|---|
+23.70% | 47.96B | |
+0.33% | 42.45B | |
+43.96% | 41.47B | |
+25.91% | 31.6B | |
+19.68% | 28.63B | |
-4.47% | 28.03B | |
+51.16% | 14.56B | |
+44.13% | 14.14B | |
+2.00% | 12.58B |